Results 11 to 20 of about 42,631 (233)

PHARYNGITIS

open access: bronzePrimary Care: Clinics in Office Practice, 1996
This article reviews the commonly encountered agents causing acute inflammation of the pharynx and tonsils, with special attention to a practical approach for identifying and dealing with the group A beta-hemolytic streptococcus. Ubiquitous viral agents such as Epstein-Barr virus, rhinovirus, and adenovirus are reviewed.
Donald B. Middleton
openaire   +3 more sources

Distribution of Streptococcal Pharyngitis and Acute Rheumatic Fever, Auckland, New Zealand, 2010–2016

open access: yesEmerging Infectious Diseases, 2020
Group A Streptococcus (GAS) pharyngitis is a key initiator of acute rheumatic fever (ARF). In New Zealand, ARF cases occur more frequently among persons of certain ethnic and socioeconomic groups.
J. Oliver   +5 more
semanticscholar   +1 more source

The incidence of sore throat and group A streptococcal pharyngitis in children at high risk of developing acute rheumatic fever: A systematic review and meta-analysis

open access: yesPLoS ONE, 2020
Background Group A streptococcal (GAS) pharyngitis has traditionally been considered the sole precursor of acute rheumatic fever (ARF). Evidence from Australia, however, suggests that GAS skin infections may contribute to the pathogenesis of ARF.
S. Pearce   +4 more
semanticscholar   +1 more source

Performance and Practicality of a Rapid Molecular Test for the Diagnosis of Strep A Pharyngitis in a Remote Australian Setting.

open access: yesAmerican Journal of Tropical Medicine and Hygiene, 2020
Over 5 days, 120 schoolchildren from two schools in the remote Kimberley region of Australia were screened for Strep A pharyngitis. Molecular point-of-care testing identified Strep A pharyngitis in 13/18 (72.2%) symptomatic children.
Janessa L. Pickering, D. Barth, A. Bowen
semanticscholar   +1 more source

An Experimental Group A Streptococcus Vaccine That Reduces Pharyngitis and Tonsillitis in a Nonhuman Primate Model

open access: yesmBio, 2019
GAS-related diseases disproportionally affect disadvantaged populations (e.g., indigenous populations), and development of a vaccine has been neglected.
Tania Rivera-Hernández   +12 more
semanticscholar   +1 more source

Pharyngeal entomophthoromycosis

open access: yesJournal of the Chinese Medical Association, 2014
We describe a rare case of entomophthoromycosis of the pharynx in a previously healthy patient, unlike other fungal infections which are seen as opportunistic infections in immunocompromised hosts. This infection is commonly seen in subtropical and tropical areas of Africa, America, and Asia.
Yu, Wan-Nien   +2 more
openaire   +2 more sources

Diagnosis and antibiotic treatment of group a streptococcal pharyngitis in children in a primary care setting: impact of point-of-care polymerase chain reaction

open access: yesBMC Pediatrics, 2019
BackgroundTo compare the sensitivity and specificity of the recommended 2-step rapid antigen detection test (RADT) with confirmatory culture vs the point-of-care (POC) polymerase chain reaction (PCR) Roche cobas® Liat® Strep A test for detection of group
A. Rao   +8 more
semanticscholar   +1 more source

Diagnosis and Management of Group a Streptococcal Pharyngitis in the United States, 2011–2015

open access: yesBMC Infectious Diseases, 2019
BackgroundClinical guidelines for the diagnosis of group A streptococcal (GAS) pharyngitis recommend the use of a rapid antigen detection test (RADT) and/or bacterial culture.
R. Luo   +5 more
semanticscholar   +1 more source

Pharyngitis

open access: yesPrimary Care: Clinics in Office Practice, 2014
Most infectious pharyngitis has a viral cause. The use of aspirin or nonsteroidal antiinflammatory agents (NSAIAs) is advised in adults and NSAIAs in children for the treatment of pain. There are several studies that show that NSAIAs relieve pharyngitis pain better than acetaminophen.
openaire   +2 more sources

Cefuroxime axetil dosing regimens and probability of target attainment in adults and children

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims Cefuroxime axetil exists in several dosage forms for oral administration, and is indicated for treatment of respiratory, genitourinary, skin and soft tissue infections. Evolving patterns of bacterial susceptibility, expressed as increasing minimum inhibitory concentrations (MICs), warrant monitoring of antibiotic efficacy.
Sven C. van Dijkman   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy